Teladoc, Inc. v. Texas Medical Board
112 F. Supp. 3d 529
W.D. Tex.2015Background
- Teladoc (telehealth company) and two Teladoc physicians sued the Texas Medical Board (TMB) after the TMB adopted New Rule 190.8 requiring an in‑person or face‑to‑face physical exam before prescribing "dangerous drugs or controlled substances."
- Teladoc’s model delivers phone‑based consultations by board‑certified physicians; Teladoc asserts telephone visits lower cost, expand access (especially in underserved/rural areas), and account for ~23% of its 2014 revenue from Texas.
- TMB previously issued an advisory letter (2011) and an emergency rule (2015) taking similar positions; state courts had enjoined the emergency rule and found the 2011 pronouncement an improper amendment of the old rule.
- Plaintiffs sought a preliminary injunction to block enforcement of New Rule 190.8 (effective June 3, 2015), alleging Sherman Act (Section 1) antitrust violation and a dormant Commerce Clause injury; the TMB declined to assert Parker immunity at the preliminary injunction stage.
- The district court held a hearing, found plaintiffs likely to succeed on the antitrust claim, that plaintiffs would suffer irreparable harm (including destruction of business model and difficulty collecting money damages), and that public‑safety justifications were inadequately supported; it enjoined enforcement of New Rule 190.8 pending final resolution.
Issues
| Issue | Plaintiff's Argument | Defendant's Argument | Held |
|---|---|---|---|
| Whether New Rule 190.8 likely violates Section 1 of Sherman Act | Rule unlawfully restrains competition by eliminating Teladoc’s telephone‑only service, raising prices and reducing access/innovation | Rule protects patient safety and improves care quality by requiring in‑person exams | Court: Plaintiffs likely to succeed; evidence shows anticompetitive effects and TMB’s quality justification is unsupported at this stage |
| Whether plaintiffs are likely to prevail on dormant Commerce Clause claim | Rule discriminates against out‑of‑state physicians serving Texas patients (burdens interstate commerce) | Rule imposes only an indirect burden on interstate commerce | Court: Declined to decide because antitrust likelihood satisfied first element for injunction |
| Whether plaintiffs will suffer irreparable harm without injunction | Teladoc would be largely displaced in Texas, harming business model, physician plaintiffs would lose income/ability to practice as‑is, and money damages may be inadequate or unrecoverable | Plaintiffs can adopt video/telemedicine alternatives or continue business elsewhere; monetary damages suffice | Court: Plaintiffs shown substantial threat of irreparable injury (business destruction, loss of growth/opportunity, and collectability concerns) |
| Balance of equities and public interest | Enjoining rule preserves access, competition, lower costs, and prevents destruction of business model pending trial | Rule protects public health and safety; anecdotal harms justify precaution | Court: Balance favors plaintiffs—TMB offered only anecdotal support and state court previously found no imminent peril from emergency rule |
Key Cases Cited
- N. Carolina State Bd. of Dental Examiners v. F.T.C., 135 S. Ct. 1101 (U.S. 2015) (states’ regulatory actions may be immune from antitrust law but require special analysis)
- Ticor Title Ins. Co. v. FTC, 504 U.S. 621 (U.S. 1992) (federal antitrust laws are subject to supersession by state regulatory programs)
- California Retail Liquor Dealers Ass’n v. Midcal Aluminum, 445 U.S. 97 (U.S. 1980) (Parker immunity requires clearly articulated state policy and active supervision)
- American Needle, Inc. v. Nat’l Football League, 560 U.S. 183 (U.S. 2010) (Section 1 reaches concerted action that restrains trade)
- Professional Engineers v. United States, 435 U.S. 679 (U.S. 1978) (rejection of public‑safety justifications as carte blanche for anticompetitive professional restraints)
- Brunswick Corp. v. Pueblo Bowl‑O‑Mat, Inc., 429 U.S. 477 (U.S. 1977) (antitrust injury must be injury to competition, not merely competitors)
- Daniels Health Scis., LLC v. Vascular Health Scis., LLC, 710 F.3d 579 (5th Cir. 2013) (plaintiff seeking preliminary injunction must show prima facie case, not summary‑judgment level proof)
- Marucci Sports, LLC v. Nat’l Collegiate Athletic Ass’n, 751 F.3d 368 (5th Cir. 2014) (rule of reason analysis requires balancing anticompetitive effects against procompetitive justifications)